Could a quick ketamine infusion lift depression in ICU patients?
NCT ID NCT07639359
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a low dose of ketamine, given as an IV infusion, can quickly improve depressive symptoms in adults who have been in the intensive care unit (ICU) for at least 6 days. About 50 participants will receive either ketamine or a placebo on two days in a row. Researchers will check mood changes and safety over the next month.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Italiano de Buenos Aires - Sede Central
RECRUITINGBuenos Aires, Buenos Aires, Argentina
-
Mayo Clinic
RECRUITINGJacksonville, Florida, 32224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a ketamine boost during surgery slash opioid needs?
- Brain zapping gets personal: a new approach to treating depression and anxiety
- Faith-Based therapy aims to heal trauma in young women
- Brain zaps tuned to your wiring: a new hope for depression?
- Could simple home workouts ease depression in afghan women?
- Antidepressants may rewire how the brain perceives control